1. Short title This Act may be cited as the Biosimilar Red Tape Elimination Act . 2. Biosimilar biological products (a) In general Section 351(k) of the Public Health Service Act ( 42 U.S.C. 262(k) ) is amended— (1) in the subsection heading, by striking or interchangeable ; (2) in paragraph (2)— (A) by striking subparagraph (B); (B) by redesignating clauses (ii) and (iii) of subparagraph (A) as subparagraphs (B) and (C), respectively, and adjusting the margins accordingly; (C) in subparagraph (A)— (i) in clause (i), by redesignating subclauses (I) through (V) as clauses (i) through (v), respectively, and adjusting the margins accordingly; (ii) in clause (i), as so redesignated by clause (i) of this subparagraph, by redesignating items (aa) through (cc) as subclauses (I) through (III), respectively, and adjusting the margins accordingly; and (iii) by striking (A) In General and all that follows through An application submitted under this subsection shall include information and inserting the following: (A) In general An application submitted under this subsection shall include information ; (D) in subparagraph (B), as so redesignated by subparagraph (C) of this paragraph, by striking clause (i)(I) and inserting subparagraph (A)(i) ; and (E) in subparagraph (C), as so redesignated by subparagraph (C) of this paragraph, by redesignating subclauses (I) through (III) as clauses (i) through (iii), respectively, and by adjusting the margins accordingly